Furthermore, elevated levels of IL-6, IL-8, VEGF, HGF, and GRO-1 found in HNSCC patients with poor survival indicate that targeting this pathway could be of therapeutic significance [225]. Here, CXCL8 is linked to head and neck squamous cell carcinoma.